Clinical Trial Update: Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating the safety and preliminary efficacy of combining azacitidine with gemtuzumab ozogamicin in relapsed acute myeloid leukemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Mylotarg (gemtuzumab ozogamicin)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: University of California, San Diego | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-02-18